Taken together, TRAIL inhibited arthritis-induced joint damage and bone absorption by suppressing osteoclast activation, suggesting a therapeutic role of TRAIL in inflammatory arthritis and regulation of osteoclastogenesis. Here, TNFSF10 is linked to arthritic joint disease.